Safety, tolerability and pharmacokinetics of the fibroblast growth factor receptor inhibitor AZD4547 in Japanese patients with advanced solid tumours: a Phase I study

Conclusions AZD4547 was well tolerated in Japanese patients, with best response of stable disease ≥4 weeks.
Source: Investigational New Drugs - Category: Drugs & Pharmacology Source Type: research